Jiri Zemlicka - Warren MI Yao-Ling Qiu - Detroit MI John C. Drach - Ann Arbor MI Roger G. Ptak - New Market MD
Assignee:
Wayne State University The Regents of the University of Michigan
International Classification:
C07D47316
US Classification:
514262, 514261, 544276, 544277
Abstract:
Compounds which are active against viruses have the following Formulas: wherein B is a purine or pyrimidine heterocyclic ring and is preferably selected from the group consisting of 6-aminopurine (adenine), 2,6-diaminopurine, 2-amino-6-azidopurine, 2-amino-6-cyclopropylaminopurine, 6-hydroxypurine (hypoxanthine), 2-amino-6-halo substituted purines, 2-amino-6-alkoxy substituted purines, 2-amino-6-hydroxypurine (guanine), 3-deazapurines, 7-deaza-purines, 8-azapurines, cytosine, 5-halo substituted cytosines, 5-alkyl substituted cytosines, thymine, uracil and 6-azapyrimidines; X is O; and, R and R are alkyl or aryl groups. The compounds of the present invention also include the R- and S-enantiomers of the above compounds. The R X and/or R X can also be amino acid residues with X as NH.
2-Hydroxymethylcyclopropylidenemethylpurines And -Pyrimidines As Antiviral Agents
Compounds which are active against viruses have the following Formulas: wherein B is a purine or pyrimidine heterocyclic ring and is preferably selected from the group consisting of 6-aminopurine (adenine), 2,6-diaminopurine, 2-amino-6-azidopurine, 2-amino-6-cyclopropylaminopurine, 6-hydroxypurine (hypoxanthine), 2-amino-6-halo substituted purines, 2-amino-6-alkoxy substituted purines, 2-amino-6-hydroxypurine (guanine), 3-deazapurines, 7-deaza-purines, 8-azapurines, cytosine, 5-halo substituted cytosines, 5-alkyl substituted cytosines, thymine, uracil and 6-azapyrimidines; X is O; and, R and R are alkyl or aryl groups. The compounds of the present invention also include the R- and S-enantiomers of the above compounds. The R X and/or R X can also be amino acid residues with X as NH.
2-Hydroxymethylcyclopropylidene Methylpurines And -Pyrimidines As Antiviral Agents
Jiri Zemlicka - Warren MI, US Yao-Ling Qiu - Hamburg PA, US John C. Drach - Ann Arbor MI, US Roger G. Ptak - New Market MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI Wayne State University - Detroit MI
International Classification:
C07D239/47 C07D239/54 A61K031/505
US Classification:
514274, 544314, 544317
Abstract:
Compounds which are active against viruses have the following Formulas: wherein B is a purine or pyrimidine heterocyclic ring and is preferably selected from the group consisting of 6-aminopurine (adenine), 2,6-diaminopurine, 2-amino-6-azidopurine, 2-amino-6-cyclopropylaminopurine, 6-hydroxypurine (hypoxanthine), 2-amino-6-halo substituted purines, 2-amino-6-alkoxy substituted purines, 2-amino-6-hydroxypurine (guanine), 3-deazapurines, 7-deaza-purines, 8-azapurines, cytosine, 5-halo substituted cytosines, 5-alkyl substituted cytosines, thymine, uracil and 6-azapyrimidines; X is O; and, Rand Rare alkyl or aryl groups. The compounds of the present invention also include the R- and S-enantiomers of the above compounds. The RX and/or RX can also be amino acid residues with X as NH.
The present invention provides phosphoramidate derivatives of a furanosyluracil analog, FAU, that can effectively deliver FAU monophosphate, or a derivative thereof, intracellularly. FAU-Phosphoramidate diesters can bypass the first step of phosphorylation and be activated intracellularly so as to be converted to nucleoside monophosphates. This results in improved formation of nucleoside triphosphates, and higher incorporation into DNA. The compounds of the invention can be used to treat cancer.
2,2-Bis-(Hydroxymethyl)Cyclopropylidenemethyl-Purines And -Pyrimidines As Antiviral Agents
Jiri Zemlicka - Warren MI, US Yao-Ling Qiu - Hamburg PA, US John Drach - Ann Arbor MI, US Roger Ptak - New Market MI, US
International Classification:
A61K 31/513
US Classification:
514269000, 544314000
Abstract:
Compounds which are active against viruses have the following Formulas: wherein B is a purine or pyrimidine heterocyclic ring and is preferably selected from the group consisting of 6-aminopurine (adenine), 2,6-diaminopurine, 2-amino-6-azidopurine, 2-amino-6-cyclopropylaminopurine, 6-hydroxypurine (hypoxanthine), 2-amino-6-halo substituted purines, 2-amino-6-alkoxy substituted purines, 2-amino-6-hydroxypurine (guanine), 3-deazapurines, 7-deaza-purines, 8-azapurines, cytosine, 5-halo substituted cytosines, 5-alkyl substituted cytosines, thymine, uracil and 6-azapyrimidines; X is O; and, Rand Rare alkyl or aryl groups. The compounds of the present invention also include the R- and S-enantiomers of the above compounds. The RX and/or RX can also be amino acid residues with X as NH.